An increase in InsP3R1 expression may contribute to multiple oncological processes, including apoptosis resistance in prostate cancer [74], autophagy induction in clear cell renal cell carcinoma [75], and proliferation, invasion, and migration in osteosarcoma [76]. This evidence concerns the gene ITPR1 and prostate carcinoma.